HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mee-Hyun Lee Selected Research

3-deoxysappanchalcone

6/2021The 3-deoxysappanchalcone induces ROS-mediated apoptosis and cell cycle arrest via JNK/p38 MAPKs signaling pathway in human esophageal cancer cells.
1/20213-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo.
8/2019Cell growth inhibition by 3-deoxysappanchalcone is mediated by directly targeting the TOPK signaling pathway in colon cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mee-Hyun Lee Research Topics

Disease

66Neoplasms (Cancer)
11/2021 - 03/2009
19Lung Neoplasms (Lung Cancer)
01/2022 - 12/2012
16Carcinogenesis
04/2019 - 08/2009
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 06/2013
10Skin Neoplasms (Skin Cancer)
01/2022 - 12/2012
10Esophageal Squamous Cell Carcinoma
09/2020 - 01/2018
9Inflammation (Inflammations)
07/2021 - 06/2012
9Colonic Neoplasms (Colon Cancer)
03/2021 - 06/2012
8Melanoma (Melanoma, Malignant)
01/2021 - 12/2012
7Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 06/2012
6Neoplasm Metastasis (Metastasis)
06/2019 - 08/2015
5Esophageal Neoplasms (Esophageal Cancer)
06/2021 - 05/2017
5Squamous Cell Carcinoma of Head and Neck
01/2019 - 04/2016
5Breast Neoplasms (Breast Cancer)
04/2018 - 03/2009
4Body Weight (Weight, Body)
01/2021 - 01/2013
4Neoplastic Cell Transformation
10/2015 - 01/2011
3Mouth Neoplasms (Oral Cancer)
07/2021 - 04/2016
3Hyperplasia
01/2021 - 11/2015
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2020 - 10/2017
3Prostatic Neoplasms (Prostate Cancer)
09/2018 - 09/2014
2Thymoma (Thymic Carcinoma)
09/2020 - 10/2017
2Ovarian Neoplasms (Ovarian Cancer)
09/2009 - 08/2009
1Hyperuricemia
07/2021
1Fibrosis (Cirrhosis)
07/2021
1Hypersensitivity (Allergy)
06/2021
1Human Influenza (Influenza)
06/2021
1Glioma (Gliomas)
01/2021

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2009
12Phosphotransferases (Kinase)IBA
07/2021 - 05/2013
8Pharmaceutical PreparationsIBA
05/2021 - 04/2016
7Gefitinib (Iressa)FDA Link
04/2021 - 07/2013
6Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2021 - 06/2012
5ErbB Receptors (EGF Receptor)IBA
01/2022 - 07/2013
5p38 Mitogen-Activated Protein KinasesIBA
12/2021 - 05/2018
5Protein Kinases (Protein Kinase)IBA
01/2021 - 06/2012
5Tyrosine Kinase InhibitorsIBA
01/2021 - 07/2013
5AgarIBA
01/2019 - 12/2012
5CarcinogensIBA
10/2018 - 08/2014
5Epidermal Growth Factor (EGF)IBA
10/2015 - 01/2011
4Annexin A5IBA
03/2021 - 08/2019
4Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2021 - 10/2017
4Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2019 - 05/2013
3licochalcone HIBA
01/2022 - 01/2019
3LignansIBA
11/2021 - 09/2020
3Podophyllotoxin (Condylox)FDA LinkGeneric
11/2021 - 06/2020
3costunolideIBA
07/2021 - 01/2021
3Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021 - 05/2018
3Matrix Metalloproteinases (MMPs)IBA
06/2021 - 08/2015
3CaspasesIBA
06/2021 - 05/2018
33-deoxysappanchalconeIBA
06/2021 - 08/2019
3Biological ProductsIBA
03/2021 - 01/2016
3Propidium (Propidium Iodide)IBA
03/2021 - 08/2019
3FlavonoidsIBA
01/2021 - 01/2019
3licochalcone BIBA
08/2020 - 04/2016
3AntioxidantsIBA
05/2020 - 04/2016
3PhytochemicalsIBA
05/2020 - 04/2015
3licochalcone CIBA
05/2020 - 12/2018
3Biomarkers (Surrogate Marker)IBA
01/2020 - 06/2016
3EnzymesIBA
12/2019 - 01/2016
3Ribosomal Protein S6 Kinases (S6 Kinase)IBA
08/2019 - 05/2013
3Cyclin D1IBA
10/2018 - 03/2014
3kaempferolIBA
01/2018 - 09/2014
3CateninsIBA
11/2017 - 12/2013
3Estrogen ReceptorsIBA
06/2017 - 03/2009
3Mitogen-Activated Protein KinasesIBA
02/2014 - 05/2013
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
07/2021 - 09/2020
2deoxypodophyllotoxinIBA
04/2021 - 09/2020
2Actin Depolymerizing Factors (Cofilins)IBA
01/2021 - 06/2019
270-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
01/2021 - 06/2013
2echinatinIBA
02/2020 - 11/2019
2licochalcone DIBA
01/2020 - 01/2019
2xanthohumolIBA
01/2020 - 01/2019
2Phosphatidylinositols (Phosphatidylinositol)IBA
01/2019 - 06/2013
2oridoninIBA
05/2018 - 01/2018
2AndrogensIBA
01/2018 - 09/2014
2LuciferasesIBA
11/2017 - 08/2015
2Therapeutic UsesIBA
10/2017 - 06/2016
2herbacetinIBA
10/2017 - 01/2016
23-hydroxyflavoneIBA
10/2017 - 09/2014
2Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
10/2017 - 01/2016
2Cyclin-Dependent Kinase Inhibitor p16IBA
06/2016 - 04/2013
2Caspase 7IBA
11/2015 - 06/2012
2magnolinIBA
08/2015 - 02/2014
2ResveratrolIBA
09/2014 - 09/2009
2polypeptide 3 90kDa ribosomal protein S6 kinaseIBA
02/2014 - 01/2011
2Peptide Elongation Factors (Elongation Factor)IBA
09/2009 - 08/2009
1Xanthine OxidaseIBA
07/2021
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
07/2021
1Uric Acid (Urate)IBA
07/2021
1potassium oxonateIBA
07/2021
1LuteolinIBA
01/2021
1atezolizumabIBA
01/2021
1SesquiterpenesIBA
01/2021
1CytokinesIBA
01/2021

Therapy/Procedure

21Therapeutics
01/2022 - 09/2009
4Chemoprevention
05/2017 - 08/2014
3Oral Administration
01/2020 - 01/2016
2Drug Therapy (Chemotherapy)
05/2021 - 05/2020
1Radiotherapy
05/2021
1Immunotherapy
01/2021